[ad_1]
Original Caption: Someone In Hong Kong Spreading Rumors After Buying Vaccines From Mainland China, And The Hong Kong Government Responded!
Author | Yang jia
▲ Data Map: VaccineHong Kong Special Administrative Region Executive Director Carrie Lam announced on the 11th that the Hong Kong government has reached a new crown vaccine procurement agreement with Kexing Company. It will purchase 7.5 million doses of the Kexing vaccine. The first batch of vaccines will arrive in Hong Kong in January next year. However, some people posted rumors on social media that the Hong Kong government used this to pass profit on to mainland China or individual companies. The RAE government issued a statement on the 14th solemnly stating that the rumors are purely hearsay, and that the rumors are deliberate and are not taken into account in the public interest.
▲ Screenshot of the press release issued by the Government of the Hong Kong Special Administrative Region on the 14thThere are rumors on social media that the request by the SAR government for the new crown vaccine is a political decision and is used to transfer benefits to the continent or to individual companies. A government spokesperson said today (December 14) that the government’s procurement of vaccines is based solely on existing scientific evidence. The goal is to ensure that the safest and most effective vaccine is provided to all Hong Kong citizens as soon as possible. Relevant rumors are purely hearsay, and rumors are deliberately unpredictable and ignore the public interest. The government expresses its extreme regret that some people have spread rumors about public health matters.
As early as September this year, the government announced that it would adopt a “dual” strategy to purchase vaccines against the new corona virus for all Hong Kong citizens. On the one hand, the government participates in the global procurement mechanism for the new corona vaccine led by the World Health Organization. It also signs pre-purchase agreements directly with individual vaccine manufacturers to obtain more vaccine supplies in advance. The purpose of signing a pre-purchase agreement is that the vaccine is still under development and prior to approval by the relevant regulatory authorities, pre-order vaccines that have a higher chance of success for supply to Hong Kong citizens.
As revealed by the World Health Organization, the new corona vaccine is primarily divided into four different technology platforms, including inactivation, viral vectors, nucleic acids, and protein subunits. The government consulted the Joint Scientific Committee on New Discoveries and Infectious Animal Diseases and Vaccine-Preventable Diseases of the Department of Health on the aforementioned technology platforms and the candidate vaccines on each technology platform that have basically entered the third phase of clinical research, and four government officials for epidemic prevention. Opinions of expert consultants against the epidemic. Experts believe that each technology platform has its own merits. They also understand that the government must buy candidate vaccines from different vaccine manufacturers and different technology platforms, and buy enough doses to supply at least twice the population of Hong Kong to spread risks and ensure sufficient Vaccines are supplied to all Hong Kong citizens.
The three vaccines previously purchased by the SAR government are developed / manufactured by Kexing Holdings (Hong Kong) Co., Ltd. (inactivated vaccine), Fosun Pharma / German pharmaceutical company BioNTech (nucleic acid vaccine) and AstraZeneca (AstraZeneca ) / Oxford University (viral vector vaccine), belonging to three different technology platforms, and scientific research technology development and clinical research are among the main vaccine candidates. Government procurement of the relevant vaccines is a decision made after consulting expert opinions on potential vaccines and taking into account factors such as vaccine supply and timing, logistics, and storage methods. Vaccine procurement decisions are based solely on safety, efficacy, quality, and supply, with absolutely no political factors involved.
A spokesperson for the RAE government emphasized: “All vaccines must first comply with relevant procedures, including approval of the third phase of clinical research and obtaining approval from the local drug regulatory authority and emergency legislation. in Hong Kong for emergency use to ensure the safety, efficacy and quality of the vaccine. Due to fierce global competition for vaccines and initial supply shortages, the government is striving to achieve an early delivery of vaccines in Hong Kong and continues to negotiate pre-purchase agreements with vaccine manufacturers. On the other hand, it will continue to rely on the latest scientific evidence and clinical data. And then consult experts to finalize specific arrangements for the vaccination plan and vaccinate citizens as soon as possible “.
The government deeply regrets that there are statements that spread false information or attempt to politicize public health problems, which will severely impact the unity of society to work together in the fight against the epidemic. To strengthen public confidence in vaccines, the government will continue to strengthen the transparency of information dissemination. Citizens can browse the World Health Organization and government websites for correct information on vaccines.
